asco 2020: latest developments in egfr-mutated non-small cell lung cancer
Published 3 years ago • 1.8K plays • Length 15:35Download video MP4
Download video MP3
Similar videos
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
5:55
a case of egfr-mutant non–small cell lung cancer
-
0:48
new standard of care for lung cancer patients with egfr mutations
-
5:26
asco 2024: lung cancer roundup
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
1:23
flaura trial demonstrates efficacy in egfr-positive lung cancer
-
1:05
advances in managing krasg12c- and egfr-mutated nsclc
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
1:44
dr. oxnard on delaying second-line treatment in egfr-mutant lung cancer
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
0:55
mariposa update - amivantamab lazertinib in 1l egfr mutated metastatic nsclc.
-
4:25
do immune checkpoint inhibitors work in egfr mutant lung cancer?
-
1:15
dr. aggarwal on triplet therapy in egfr-mutant lung cancer
-
2:51
early results from a 3rd gen egfr-tki in advanced nsclc
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?